Xtant Medical Holdings, Inc. (XTNT)

↓ Download CSV

CIK 0001453593 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Xtant Medical Holdings, Inc. reported revenue of $133.93M, up 14.2% from the prior year. The company was profitable, with a net margin of 3.7% and a gross margin of 62.9%. It held $94.14M in total assets against $43.19M in total liabilities.

Key ratios (FY2025)

62.9%
Gross margin
5.4%
Operating margin
3.7%
Net margin
9.8%
Return on equity
+14.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$133.93M$117.27M$91.30M$57.97M$55.26M$53.34M$64.68M$72.20M
Cost of Revenue$49.65M$49.05M$35.84M$25.83M$22.77M$18.95M$22.17M$28.72M$32.51M$27.71M
Gross Profit$84.27M$68.22M$55.47M$32.14M$32.49M$34.39M$42.52M$43.49M$50.10M$62.29M
Operating Income$7.28M-$12.07M-$10.16M-$6.75M-$3.85M-$751.0K-$2.25M-$60.08M-$37.83M-$7.55M
Net Income$4.97M-$16.45M$660.0K-$8.48M-$4.85M-$7.02M-$8.22M-$70.10M-$52.41M-$19.49M
EPS (Diluted)$0.03$-0.12$0.01$-0.09$-0.06$-0.25$-0.63$-5.97$-34.76$-18.46
Total Assets$94.14M$93.84M$92.61M$60.23M$54.69M$41.47M$43.16M$46.42M$105.70M$144.10M
Total Liabilities$43.19M$50.87M$41.26M$26.06M$23.81M$26.95M$87.36M$90.19M$164.40M$151.17M
Shareholders' Equity$50.95M$42.96M$51.35M$34.17M$30.88M$14.51M-$44.20M-$43.77M-$58.70M-$7.07M
Cash & Equivalents$17.05M$6.20M$5.71M$20.30M$18.24M$2.34M$5.24M$6.80M$2.86M$2.58M
Operating Cash Flow$12.55M-$11.90M-$9.52M-$5.34M$439.0K-$731.0K-$413.0K$1.21M-$543.0K-$14.41M
Capital Expenditures$2.38M$4.11M$1.46M$1.76M$2.12M$1.54M$879.0K$624.0K
Shares Outstanding140.04M139.05M130.18M108.87M87.07M77.57M13.16M13.17M1.51M1.44M